Vizient® is proud to announce that the Vizient Clinical Data Base was recognized by Modern Healthcare as one of the Best in ...

New York-based medical devices firm Endure Industries Inc. lost its appeal in a monopolization lawsuit against Vizient Inc. as the Fifth Circuit affirmed a lower court’s finding that the company ...

Vizient ®, the nation’s largest provider-driven healthcare performance improvement company, today announced a renewed and expanded agreement with AdventHealth, one of the largest non-profit health ...

The future chief quality executive role demands strategic leadership, emotional intelligence, and systems thinking to improve clinical outcomes ...

IRVING, Texas--(BUSINESS WIRE)--Vizient announced it has published its annual corporate responsibility report detailing its focus on driving positive impacts across three interconnected pillars – ...

Tulavi Therapeutics announced its allay™ Hydrogel Cap has received an Innovative Technology contract from Vizient® the nation ...

Healthcare performance improvement and analytics company Vizient is collaborating with Civica Rx, a company that works to ensure essential generic medications are available and affordable to everyone, ...

Ambient AI medical documentation company Augmedix, a wholly-owned subsidiary of Commure, has been awarded a contract with Vizient, a healthcare performance improvement company, for Augmedix’s AI suite ...

Drug prices for hospitals are expected to increase by 3.09% in the coming year with newfound COVID-19 treatment remdesivir (Veklury) edging out longtime leader adalimumab (Humira) as hospitals’ top ...

IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced it is again expanding the product portfolio for its Novaplus Enhanced Supply Program. The program is adding six additional essential ...

Group purchasing organization Vizient and other medical supply chain leaders testified before Congress July 30 emphasizing the need for greater transparency in the medical supply chain and detailing ...

Drugs used for ventilator patients—such as sedatives and neuromuscular blockers—are running low. Healthcare performance company Vizient identified looming potential shortages among 13 drugs (PDF) ...